Consultant Nephrology Division Department of Medicine

Slides:



Advertisements
Similar presentations
2 cases of hypertension Year 1 Michaelmas term 2006.
Advertisements

SHAHKUR SHABIR GP REGISTRAR DR ELLA RUSSELL -GP TRAINER SUNNYBANK MEDICAL CENTRE OCT 2011.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
Assessment and Management of Patients With Hypertension.
Nursing 210 Advanced Cardiac UNIT 2 Laurie Brown RN, MSN, MPA-HA, CCRN.
Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Blood Pressure Monitoring
BLOOD PRESSURE.  The difference between the systolic and diastolic pressure (approximately 40 mm Hg) is called the pulse pressure.
Hypertension Dr. Meg-angela Christi Amores. Hypertension doubles the risk of cardiovascular diseases present in all populations except for a small number.
In the Name of God In the Name of God Overview of Hypertension Mahboob Lessan Pezeshki MD Tehran University of Medical Sciences Aban 1392.
Case HYPERTENSION Source: NCHS and NHLBI. Hypertension is defined as SBP 140 mm Hg or DBP 90 mmHg, taking antihypertensive medication, or being.
Implementing NICE guidance
Drugs for Hypertension
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
HOME AND AMBULATORY BLOOD PRESSURE MONITORING
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
Nursing Management of Clients with Stressors of Circulatory Function HYPERTENSION NUR133 LECTURE # 10 K. Burger MSEd,MSN, RN, CNE.
Lessons from Hypertension guidelines :
FAME HTN Mohsen. Epidemiology and stuff  About 1/3 of middle aged patients have hypertension  About ½ of elderly patients have hypertension.  Responsible.
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.
Blood Pressure Hypertension is a major risk factor for heart disease and stroke. As the first and fourth leading causes of death in the United States.
NICE GUIDELINES HYPERTENSION Masroor Syed. Latest Issue June 2006 Evidence Based uickrefguide.pdf
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Blood pressure control in primary health care WORKSHOP
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Radka Adlová Arterial hypertension and preventive cardiology.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Antihypertensive Drugs
وزارة التعليم العلي والبحث العلمي جامعة الكوفة مركز تطوير التدريس والتدريب الجامعي Hypertension & Its Impacts on Human Health الدكتور سامر نعمة ياسين الفتلاوي.
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
1 Dr. Zahoor Ali Shaikh. HYPERTENSION DEFINITION  Hypertension is said to be present when blood pressure is greater than expected for a person of particular.
Hypertension in primary care
Management of Hypertension according to JNC 7
Clinical Management of primary hypertension
Blood Pressure Hypertension Orthostatics
Diagnosis and initial management of hypertension in primary care
Hypertension guidelines What’s all the controversy about 2015
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Defining hypertension
Nursing Care of Patients with Hypertension
Hypertension.
Drugs for Hypertension
Hypertension.
HYPERTENSION.
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Hypertension Pharmcology.
Consultant Nephrology Division Department of Medicine
Achieving the Clinical Potential of RAAS Blockade
UNIT 2: ANTIHYPERTENSIVE DRUGS
Essential Hypertension
Department of General Practice QUB
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Primary Hypertension Max C. Reif, M.D.
Anti hypertensive Drugs
Chapter 32 Assessment and Management of Patients With Hypertension
Pharmacological Treatment of Hypertension Update 2012
Pathology Of Hypertension
Hypertension Implementing NICE guidance 2 nd Edition March 2013 NICE clinical guideline 127.
Hypertensive Crisis Halmat M. Jaafar (MSc. Clinical pharmacy)
Presentation transcript:

Consultant Nephrology Division Department of Medicine HYPERTENSION Prof. Jamal Al Wakeel Consultant Nephrology Division Department of Medicine 1

The Objectives of this Lecture are: To be able to recognize the definition of hypertension To be able to identify the Stages of Hypertension To find out the complication of Hypertension To learn how to measure blood pressure To acquire knowledge on how to treat hypertension

Case 47 year old man came to your clinic with headache for 3 weeks. The nurse measure his Blood Pressure and was found to be 150/95 mmHg: Does he have Hypertension? What is the stage of Hypertension? What investigation should you perform? What could be your management on his case? Is their any possible prevention to his disease and its complication?

HYPERTENSION Onset stage 25-55 years mainly in 40-50y The 4th most common cause of death worldwide Directly and indirectly responsible for >20% of all deaths 29-30% (about 66 million, 1 out of very 3) incidence of hypertension adult of the United States. Onset stage 25-55 years mainly in 40-50y Occurs over 30%of persons older than 65 y

Prevalence, Awareness, Treatment, and Control of Hypertension among Saudi Adult Population: A National Survey The overall prevalence of hypertension was 25.5% Only 44.7% of hypertensives were aware 71.8% of them received pharmacotherapy only 37.0% were controlled. Source: International Journal of Hypertension Abdalla A. Saeed, Nasser A. Al-Hamdan Volume 2011 (2011), Article ID 174135, 8 pages

Prevalence of High Blood Pressure inAdults Age 20 and Older NHANES: 2007–2010 Source: NCHS and NHLBI. Hypertension is defined as SBP 140 mm Hg or DBP 90 mmHg, taking antihypertensive medication, or being told twice by a physician or other professional that one has hypertension.

Hypertension In 90%-95% of cases no cause can be found primary hypertension (essential) Secondary hypertension 5-10%

Mechanism of Blood Pressure: Blood Pressure = Cardiac output X Systemic Vascular Resistance = CO X SVR = Stroke volume X HR X SVR

Essential HTN Risk factors Obesity---metabolic syndrome Excessive salt intake---low potassium intake Excessive alcohol intake Polycythemia Lack of exercise Non-steroid anti-inflammatory drugs Family history of essential HTN Caffeine and smoking increase the BP acutely but are not risk factors for the development of chronic essential HTN

Secondary Hypertension Primary renal disease Oral contraceptives Sleep apnea syndrome Primary hyperaldosteronism Renovascular disease Cushing’s syndrome Pheochromocytoma Other endocrine disorders Coarctation of the aorta

Definitions of hypertension by office and out-of-office blood pressure levels Category Systolic BP (mmHg) Diastolic (mmHg) Office BP ≥140 and/or ≥90 Ambulatory BP Daytime (or awake) ≥135 ≥85 Nighttime (or sleep) ≥120 ≥70 24 h ≥ 130 ≥80 Home BP 2013 ESH and ESC Guidelines

European Society of Nephrology Classification of Blood Pressure Levels Category Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Optimal blood pressure <120 <80 Normal blood pressure <130 <85 High-normal blood pressure 130-139 85-89 Grade 1 hypertension (mild) 140-159 90-99 Grade 2 hypertension (moderate) 160-179 100-109 Grade 3 hypertension (severe) >/= 180 >/= 110 Isolated systolic hypertension >140 <90

National Institute for Health and Clinic Excellence Hypertension Guidelines 2011 (UK) Stage 1 Clinical Blood Pressure – 140/90 mmHg Ambulatory Blood Pressure day time Monitoring (ABPM) – 135/85 mmHg Home Blood Pressure Monitoring (HBPM) - 135/85 mmHg Stage 2 Clinical Blood Pressure – 160/100 mmHg Ambulatory Blood Pressure day time Monitoring (ABPM) – 150/95 mmHg Home Blood Pressure Monitoring (HBPM) - 150/95 mmHg Severe hypertension (Stage 3) Clinical Blood Pressure – 180/110 mmHg

Type of Instrument of Blood Pressure Measurement Sphygmomanometer

Type of Instrument of Blood Pressure Measurement Home Blood Pressure Monitoring

Ambulatory Pressure Monitoring

Blood Pressure Apply to adults on no antihypertensive medications and who are not acutely ill. If there is a disparity in category between the systolic and diastolic pressures, the higher value determines the severity of the hypertension. Measure blood pressure to arm the high reading.

Office blood pressure measurement To allow the patients to sit for 3–5 minutes before beginning BP measurements Back straight and arm supported at heart level Take at least two BP measurements, spaced 1–2 min apart, and additional measurements if the first two are quite different. Consider the average BP if deemed appropriate. To use a standard bladder (12–13 cm wide and 35 cm long) A larger bladder for larger arm (circumference >32 cm) The bladder of the pressure cuff should encircle at least 80% of the upper arm

Office blood pressure measurement Place the cuff at the heart level, whatever the position of the patient. Measure BP in both arms at first visit to detect possible differences. In this instance, take the arm with the higher value as the reference. Measure BP in sitting and standing position in elderly subjects and diabetic patients Use phase I and V (disappearance) Korotkoff sounds to identify systolic and diastolic BP, respectively.

Korotkoff sounds

The diagnosis of mild hypertension should not be made until the blood pressure has been measured on at least three to six visits Average of 10 to 15 mmHg decrease between visits 1 and three

White Coat Hypertension Approximately 20 to 25% of patients with mild office hypertension More common in elderly Infrequent in patients with office diastolic pressures ≥105 mmHg

COMPLICATIONS Renal Disease Hypertension Peripheral Vascular Disease CAD, ECG, Arrthymia, Sudden Death Stroke, Ischemia, Hemorrhage, Alzheimer’s Disease, Cognitive, retinal hemorrhage Renal Disease Peripheral Vascular Disease Hypertensive Emergency And Increase Emergency Morbidity CHF LVH Aortic Dissection COMPLICATIONS Hypertension is an important contributing risk factor for morbidity and mortality from both cardiovascular (CV) and renal disease. Hypertension is one of the most significant contributing factors to the development of CV and renal disease. Complications of hypertension include coronary artery disease, congestive heart failure, stroke, renal disease (including end-stage renal disease), and peripheral vascular disease. These diseases account for significant disability, loss of productivity, and decreased quality of life for many Americans. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.

This left ventricle is very thickened (slightly over 2 cm in thickness), but the rest of the heart is not greatly enlarged. This is typical for hypertensive heart disease. The hypertension creates a greater pressure load on the heart to induce the hypertrophy.

The left ventricle is markedly thickened in this patient with severe hypertension that was untreated for many years. The myocardial fibers have undergone hypertrophy.

Hypertensive Emergency Severe hypertension (diastolic blood pressure above 120 mmHg) in end organ damage (MI,STROKE,AKI,CHF) Hypertensive Urgency Severe hypertension (diastolic blood pressure above 120 mmHg) in asymptomatic patients There is no proven benefit from rapid reduction in BP in asymptomatic patients who have no evidence of acute end-organ and are little short-term risk

Malignant (Accelerated) Hypertension Marked hypertension with encephapapathy& retinal hemorrhages, exudates, or papilledema Associated with a diastolic pressure above 120 mmHg

HYPERTENSIVE RETINOPATHY Grade Description I Minimal narrowing of retinal arteries II Narrowing of retinal arteries in conjunction with regions of focal narrowing and arterio-venous nipping III Abnormalities seen in Grade 1 and II, as well as retinal hemorrhages, hard exudation and cotton wool spots. IV Abnormalities encountered in Grades I through III, as well as swelling of the optic nerve head and macular star

Hypertensive Retinopathy Grade 1 Generalized arteriolar constriction-seen as `silver wiring` and Vascular tortuosities

Copper wiring

Hypertensive Retinopathy Grade 2 Arteriovenous nicking in association with hypertension Grade 2 (yellow arrow)

Hypertensive Retinopathy Grade 3 Flame-shaped hemorrhage in association with severe hypertension Grade 3 (yellow arrow)

Hypertensive Retinopathy Grade 4 Papilledema from malignant hypertension. There is blurring of the borders of the optic disk with hemorrhages (yellow arrows) and exudates (white arrow)

Diagnosis Hypertension Clinical Presentations: Asymptomatic Headache Epistaxis Chest discomfort Symptom of complications Screening: Every two years for persons with systolic and diastolic pressures below 120 mmHg and 80 mmHg Yearly for persons with a systolic pressure of 120 to 139 mmHg OR Diastolic pressure of 80-89 mmHg

Physical Examination Confirm the diagnosis of hypertension Detect causes of secondary hypertension Assess CV risk Organ damage Concomitant clinical conditions.

Laboratory Tests Routine Tests Electrocardiogram Urinalysis Serum sodium, serum potassium, creatinine, or the corresponding estimated GFR, and calcium Blood glucose, and hematocrit Lipid profile, after 9- to 12-hour fast, that includes high density and low-density lipoprotein cholesterol, and triglycerides Optional tests Measurement of urinary albumin excretion or albumin/creatinine ratio More extensive testing for identifiable causes is not generally indicated unless BP control is not achieved

Who should be treated? If the systolic pressure is persistently ≥140 mmHg and/or the diastolic pressure is persistently ≥90 mmHg after three to six visits.

Benefits of Lowering BP Average Percent Reduction Stroke incidence 35–40% Myocardial infarction 20–25% Heart failure 50% Renal Failure 35-50%

Blood Pressure Target: (UK) Age < 80 yrs <140/90 mmHg Age > 80 yrs 140 - 150/90 mmHg Diastolic BP Diastolic BP <90 mmHg DM and CKD <85 mmHg

TREATMENT OF HYPERTENSION Lifestyle modifications High normal SBP >130 – 139 mmHg DBP 85 – 89 mmHg in high risk patients Drug therapy If BP is 140/90 mmHg

Lifestyle changes: Salt restriction to 5-6 gm/day. Increased consumption of vegetables, fruits and low-fat dairy products. 7-8 servings/day of grain/grain products, 4-5 vegetable, 4-5 fruit Reduction of weight to BMI of 25 kg/m2. Regular exercise (≥30 min of moderate dynamic exercise on 5-7 days per week) Smoking cessation

Anti-hypertensive Medications and Complications Diuretics → Hypokalemia β-Adrenergic Blocking Agents → Bradycardia Angiotensin-Converting Enzyme Inhibitors → Hyperkalemia + cough Angiotensin II Receptor Blockers → Hyperkalemia Calcium Channel Blocking Agents → Edema + Tachycardia + Bradycardia α-Adrenoceptor Antagonists → 1st dose hypotension Drugs with Central Sympatholytic Action → Drowsiness Arteriolar Dilators → Tachycardia + Edema

Summary of antihypertensive drug treatment Key A – ACE inhibitor B-angiotensin II receptor blocker (ARB)12 C – Calcium- channel blocker (CCB)13 D – Thiazide-like diuretic Resistant hypertension A + C + D + consider further diuretic14, 15 or alpha- or beta-blocker16 Consider seeking expert advice Aged over 55 years or black person of African Step 4 Step 3 Step 2 Step 1 A + C + D A&B Aged under 55 years C &D A(B) + C or A(B)+D B + C + D 12 Choose a low-cost ARB. 13 A CCB is preferred but consider a thiazide-like diuretic if a CCB is not tolerated or the person has edema, evidence of heart failure or a high risk of heart failure. 14 Consider a low dose of spironolactone15 or higher doses of a thiazide-like diuretic. 15 At the time of publication (August 2011), spironolactone did not have a UK marketing authorization for this indication. Informed consent should be obtained and documented. 16 Consider an alpha- or beta- blocker if further diuretic therapy is not tolerated, or is contraindicated or ineffective.

Combination Therapies ACE inhibitors and diuretics Angiotensin II receptor antagonists and diuretics Calcium antagonists and ACE inhibitors Angiotensin II receptor antagonists & -adrenergic blockers or ACEI NOT RECOMMENDED Other combinations (-adrenergic blockers and diuretics)

Possible combinations of classes of antihypertensive drugs Possible combinations of classes of antihypertensive drugs. Green continuous lines: preferred combinations; green dashed line: useful combination (with some limitations); black dashed lines: possible but less well-tested combinations; red continuous line: not recommended combination. Although verapamil and diltiazem are sometimes used with a beta-blocker to improve ventricular rate control in permanent atrial fibrillation, only dihydropyridine calcium antagonists should normally be combined with beta-blockers. 2013 ESH and ESC Guidelines

Drug Therapy A low dose of initial drug should be used, slowly titrating upward. Optimal formulation should provide 24-hour efficacy with once-daily dose. Combination therapies may provide additional efficacy with fewer adverse effects.

Hypertension Renal Denervation A Controlled Trial of Renal Denervation for Resistant Hypertension. This blinded trial did not show a significant reduction of systolic blood pressure in patients with resistant hypertension 6 months after renal-artery denervation as compared with a sham control Source: The New England Journal of Medicine April 10, 2014

An implantable device designed to activate baroreceptors to reduce blood pressure does not appear to reduce blood pressure

Follow-up And Monitoring Patients should return for follow-up after 2- 4 weeks and adjustment of medications until the BP goal is reached More frequent visits for stage 2 HTN or with complicating co-morbid conditions. Serum potassium and creatinine monitored 1–2 times per year.

High Risk Group Therapy Start in pre-hypertension (130 – 139)/(85 – 89) mmHg Lifestyle change Drug therapy (If BP is 140/90 mmHg) CHF – Thiazide, ACE-1, Aldosterone, BB Post Myocardial Infarction – BB, ACEi Diabetes Mellitus – ACEi, ARB, Thiazide, CCB CKD – ACEi, ABB, Thiazide Stroke – CCB +ACEi